Mayur Somaiya
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Mayur Ian Somaiya is currently Chief Financial Officer at NewAmsterdam Pharma Co. NV since 2023.
Former roles include Managing Director & Senior Research Analyst at Piper Sandler & Co. (2010–2013), Managing Director at Thomas Weisel Partners LLC (2003–2009), Managing Director & Senior Analyst at Nomura Securities International, Inc. (2013–2016), Managing Director & Analyst at BMO Capital Markets Corp.
(2016–2018), Managing Director at Piper Sandler Cos., Analyst at Prudential Securities (1997–1999), Senior Analyst at Morgan Stanley & Co. LLC (2000–2002), Consultant at Carson Group, Inc. (New York) (1996–1997), Chief Financial Officer at TCR² Therapeutics, Inc. (2018–2021), and Chief Financial & Business Officer at Elucida Oncology, Inc. (2021–2023).
Education includes an undergraduate degree from New York University, conferred in 1995.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-20 | 58,382 ( 0.05% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Director of Finance/CFO | 2023-10-22 |
| Companies | Position | End |
|---|---|---|
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Director of Finance/CFO | 2023-06-30 |
| TCR2 THERAPEUTICS INC. | Director of Finance/CFO | 2021-12-09 |
BMO Capital Markets Corp. (Broker)
BMO Capital Markets Corp. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2018-03-31 |
Nomura Securities International, Inc.
Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2015-12-31 |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2013-10-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Prudential Securities
Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Thomas Weisel Partners LLC
Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Carson Group, Inc. (New York)
Carson Group, Inc. (New York) Investment ManagersFinance Provides financial advisory and investment services | Finance |
Nomura Securities International, Inc.
Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BMO Capital Markets Corp. (Broker)
BMO Capital Markets Corp. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Piper Sandler Cos.
Piper Sandler Cos. Investment Banks/BrokersFinance Provides investment banking and financial services | Finance |
NewAmsterdam Pharma Co. NV
NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions